We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
Square Mile Farms (SMF) is a company that installs innovative and productive vertical farms in a workplace to engage employees and help businesses create a culture of healthy, low-impact living. Its 'Office Farming' model creates green spaces for engagement and collaboration. In 2019, it was invited to build a vertical farm in Paddington Central by British Land, one of UK’s largest landowners. The setup now acts as a hub for the company's office farm installations and a base from which it can conduct Research and Development (R&D). SMF's customers include Grosvenor Group Limited and Vodafone. Moreover, the company has been covered by media platforms such as BBC One and BBC Radio. It will use 45% of the investment for sales and business development, 15% for design and technology up-gradation, 15% for raising its profile and increasing brand awareness, and 25% for operations.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £504,118
Advanced Blast & Ballistic Systems (ABBS) is a company that has developed globally patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. As per reports, mines and IEDs accounted for over 80% of UK and US army casualties in Iraq & Afghanistan. ABBS believes that its products can keep occupants inside a vehicle completely safe from the aforementioned explosive devices. The armoured vehicle protection market has a value of about $20 billion wherein ABBS aims to be a major contender. The company has received £2 million-plus revenues till date from Research and Development (R&D) grants in the UK, as well as, sold its products to the US Army and Israel with profits worth £145,000 in 2018 and £560,000 in 2019 respectively. It will use the investment to bring its products to more markets globally.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £445,814
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £532,311
Antaco is a company that deals in waste management by converting it into neutral solid biofuel using their patented technology. The global water sector is estimated to present a £15 billion opportunity. To date, the company has raised £5.8 million, including an £857,000 grant from the UK government and has also signed a contract with its first customer (Swiss Public Utility). With the proceeds, the company will build up their in-house capacity, increase enhancement of existing plant and hire subcontractors to install and commission plant.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £570,840
Jeeni is an online entertainment service that aims to harness the growing reach of streamed music. It has close to 350 million subscribers and a growth rate of 39% Year-on-Year (YoY) providing billion-dollar revenues for digital disruptors. The Jeeni prototype was launched in April 2019. The company asserts that it offers artists an ethical revenue share. Five revenue streams are operating in parallel on the Jeeeni platform, namely, subscription-based memberships, online masterclasses, bespoke hardware sales, pay-to-view streamed events, and branded merchandise sales. The company's long term goal is to surpass its target paid subscriber numbers, achieve high subscriber growth and exit by acquisition. The investment raised will be used to further scale the company's capacity globally and build its mass artist showcases.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £118,854
Gively is an online marketplace where users can give and get secondhand items for free. The secondhand clothing market will double in value to £50 billion annually by 2023, and the company finds itself as a suitable contender in this domain. They aim to lower greenhouse gas emissions and minimise landfill sites through its portal. The company has reached over 5,000 users, 70% of which came from unpaid channels. Gively won an SME (Small and medium enterprises) grant worth £10,000 of television advertising and has received rave reviews from its users through the App Store, social media, and in person. They will use 50% of the investment for marketing purposes, 25% for technology up-gradation, and 25% for hiring human resources.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £105,207
pluumo makes sustainable thermal packaging material from waste feathers. The company asserts that fresh food deliveries need thermal packaging to keep ingredients frozen and prevent spoilage. pluumo claims that plastics such as Expanded Polystyrene (EPS) are used in this process, leading to 141,000 tons of plastic waste generated in the EU in 2019. pluumo asserts that its patent-pending material matches the performance of EPS, keeping items chilled for up to 40 hours. The company has secured £450,000 in grants/awards, including £140,000 via InnovateUK. It aims to be a contender in the $137 billion online food delivery industry. pluumo argues that 74% of consumers would pay more for green packaging, with e-commerce sustainable packaging predicted to be worth $65 billion by 2023. The company will use the investment to scale production and expand into the wider UK market.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £511,325
envoPAP is a company that specialises in manufacturing printing and packaging materials from agricultural waste. Started in 2015, the company has achieved £7.3 million in revenues across 45 countries. The European packaging market is valued at over £100 billion and the European Union (EU)are looking to ban some single-use plastic products with effect from 2021, envoPAP aims to capitalise on these developments. The year 2019 saw envoPAP introducing its product 'envoBarrier’- a material resistant to oil, water, and grease which won the 'Packaging Innovation of the Year' at the Business Green Technology Awards. In 2020, envoPAP became a certified B Corporation rendering it a business that balances purpose and profit. The investment will be used to protect its Intellectual Property (IP) and expand its team.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £381,128
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph